Literature DB >> 824636

Prospects for new vaccines.

A J Beale.   

Abstract

Mesh：

Substances：

Year:  1976        PMID： 824636      PMCID： PMC2495901          DOI： 10.1136/pgmj.52.611.587

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  20 in total

1.  Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial.

Authors:  D A Stevens; G W Jordan; T F Waddell; T C Merigan
Journal:  N Engl J Med       Date:  1973-10-25       Impact factor: 91.245

2.  Implantation and use of a subcutaneous culture chamber in laboratory animals.

Authors:  R J Arko
Journal:  Lab Anim Sci       Date:  1973-02

3.  Inhibition of respiratory virus infection by locally applied interferon.

Authors:  T C Merigan; S E Reed; T S Hall; D A Tyrrell
Journal:  Lancet       Date:  1973-03-17       Impact factor: 79.321

4.  Use of recombination in the production of influenza vaccine strains.

Authors:  D McCahon; A S Beare; G C Schild; T S Hall
Journal:  Postgrad Med J       Date:  1973-03       Impact factor: 2.401

5.  Immunity to Marek's disease induced by glutaraldehyde-treated cells of Marek's disease lymphoblastoid cell lines.

Authors:  P C Powell
Journal:  Nature       Date:  1975-10-23       Impact factor: 49.962

6.  Use of temperature-sensitive mutants of influenza A virus as live virus vaccine strains. Evaluation in laboratory animals, adults and children.

Authors:  B R Murphy; D D Richman; S B Spring; R M Chanock
Journal:  Postgrad Med J       Date:  1976-06       Impact factor: 2.401

7.  The immunopurification of tetanus toxoid.

Authors:  M Hughes; R O Thomson; P Knight; J Stephen
Journal:  J Appl Bacteriol       Date:  1974-12

8.  A controlled field trial of a serogroup A meningococcal polysaccharide vaccine.

Authors:  M H Wahdan; F Rizk; A M el-Akkad; A A el-Ghoroury; R Hablas; N I Girgis; A Amer; W Boctar; J E Sippel; E C Gotschlich; R Triau; W R Sanborn; B Cvjetanović
Journal:  Bull World Health Organ       Date:  1973-06       Impact factor: 9.408

9.  A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.

Authors:  H H Erwa; M A Haseeb; A A Idris; L Lapeyssonnie; W R Sanborn; J E Sippel
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

10.  Cellular kinetics of the intestinal immune response to cholera toxoid in rats.

Authors:  N F Pierce; J L Gowans
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.